Drugs / PRP-Tetanus Conjugate Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01062477 Comparator | Jan 2010 → Sep 2011 | diphtheria, haemophilus infectious disease, pertussis, tetanus | Sanofi | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP-Tetanus Conjugate Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01062477 ↗ |
| Modality | Vaccine | “DTaP Combined Vaccine and PRP-Tetanus Conjugate Vaccine” NCT01062477 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular (each vaccine)” NCT01062477 ↗ |